Status:
TERMINATED
An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext
Lead Sponsor:
Repros Therapeutics Inc.
Conditions:
Uterine Fibroids
Eligibility:
FEMALE
18-50 years
Phase:
PHASE2
Brief Summary
An open label, extension study for subjects completing the ZPU-003 Ext 1 study.
Detailed Description
This is an open label, extension study for subjects completing the ZPU-003 Ext 1 study and an off-drug interval (menses), prior to the start of the first 16-week dosing cycle. Subjects will receive a ...
Eligibility Criteria
Inclusion
- Four subjects at one site whom have completed ZPU 003 Ext 1 study
Exclusion
- All other subjects
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT00958893
Start Date
June 1 2008
End Date
August 1 2009
Last Update
August 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Advances in Health, Inc.
Houston, Texas, United States, 77030